Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
Clinical trial NCT03527238 · COMPLETED
Trial details
- NCT number
- NCT03527238
- Sponsor
- University of Florida
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2020-06-02
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.